EP0866702A4 - Verfahren zur schmerzbehandlung - Google Patents

Verfahren zur schmerzbehandlung

Info

Publication number
EP0866702A4
EP0866702A4 EP96942906A EP96942906A EP0866702A4 EP 0866702 A4 EP0866702 A4 EP 0866702A4 EP 96942906 A EP96942906 A EP 96942906A EP 96942906 A EP96942906 A EP 96942906A EP 0866702 A4 EP0866702 A4 EP 0866702A4
Authority
EP
European Patent Office
Prior art keywords
treating pain
pain
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96942906A
Other languages
English (en)
French (fr)
Other versions
EP0866702A1 (de
Inventor
Charles H Mitch
Harlan E Shannon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP0866702A1 publication Critical patent/EP0866702A1/de
Publication of EP0866702A4 publication Critical patent/EP0866702A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Processing Of Meat And Fish (AREA)
EP96942906A 1995-12-07 1996-12-05 Verfahren zur schmerzbehandlung Withdrawn EP0866702A4 (de)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US829895P 1995-12-07 1995-12-07
US830695P 1995-12-07 1995-12-07
US831395P 1995-12-07 1995-12-07
US831295P 1995-12-07 1995-12-07
US831895P 1995-12-07 1995-12-07
US829595P 1995-12-07 1995-12-07
US831995P 1995-12-07 1995-12-07
US8318P 1995-12-07
US8319P 1995-12-07
US8306P 1995-12-07
US8298P 1995-12-07
US8313P 1995-12-07
US8295P 1995-12-07
US8312P 1995-12-07
PCT/US1996/019390 WO1997020556A1 (en) 1995-12-07 1996-12-05 Method for treating pain

Publications (2)

Publication Number Publication Date
EP0866702A1 EP0866702A1 (de) 1998-09-30
EP0866702A4 true EP0866702A4 (de) 2001-07-25

Family

ID=27567403

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96942906A Withdrawn EP0866702A4 (de) 1995-12-07 1996-12-05 Verfahren zur schmerzbehandlung

Country Status (14)

Country Link
EP (1) EP0866702A4 (de)
JP (1) JP2000501711A (de)
KR (1) KR19990071977A (de)
CN (1) CN1208348A (de)
AU (1) AU715645B2 (de)
CA (1) CA2239732A1 (de)
CZ (1) CZ174598A3 (de)
EA (1) EA199800535A1 (de)
HU (1) HUP0000110A3 (de)
IL (1) IL124786A0 (de)
NO (1) NO982582L (de)
NZ (1) NZ324594A (de)
PL (1) PL327144A1 (de)
WO (1) WO1997020556A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2206244T3 (es) 1999-06-04 2004-05-16 Eli Lilly And Company 7-ox-2-azabiciclo(2.2.1)heptanos como antagonistas selectivos del receptor muscarinico.
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (de) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Missbrauchssichere flüssigkeitsfülldosierform mit verlängerter freisetzung
BR112021016457A2 (pt) * 2019-02-22 2021-10-13 Karuna Therapeutics, Inc. Composto, medicamento e método para tratar dor ou um distúrbio do sistema nervoso central em um paciente que precisa do mesmo
WO2021097427A1 (en) 2019-11-15 2021-05-20 Karuna Therapeutics, Inc. Xanomeline derivatives and methods for treating neurological disorders
CN115974863A (zh) * 2021-10-14 2023-04-18 南京迈诺威医药科技有限公司 占诺美林衍生物的苹果酸盐、a晶型及其制备方法和用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041455A (en) * 1989-02-22 1991-08-20 Novo Nordisk A/S Piperidine compounds and their preparation and use
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5260314A (en) * 1990-08-21 1993-11-09 Novo Nordisk A/S Certain 3-(1,2,5-oxa- or thiadiazol-4-yl)-1-azabicyclo [2.2.2]octanes having pharmaceutical properties
WO1994020495A1 (en) * 1993-03-05 1994-09-15 Novo Nordisk A/S Heterocyclic compounds and their preparation and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5605701A (en) * 1995-02-17 1997-02-25 Eli Lilly And Company Transdermal formulation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041455A (en) * 1989-02-22 1991-08-20 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5260314A (en) * 1990-08-21 1993-11-09 Novo Nordisk A/S Certain 3-(1,2,5-oxa- or thiadiazol-4-yl)-1-azabicyclo [2.2.2]octanes having pharmaceutical properties
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
WO1994020495A1 (en) * 1993-03-05 1994-09-15 Novo Nordisk A/S Heterocyclic compounds and their preparation and use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CORNPROPST ET AL.: "Determination of the muscarinic agent [(3-(3-1-butylthio)-1,2,5-thiadiazol-4-yl)-1-azabicyclo[2.2.2]octane] in rat, rabbit, and monkey plsma, using HPLC in conjuction with tandem mass spectrometry", JOURNAL OF CHROMATOGRAPHY B, vol. 673, no. 1, 3 November 1995 (1995-11-03), netherlands, pages 67 - 74, XP002166840 *
See also references of WO9720556A1 *

Also Published As

Publication number Publication date
WO1997020556A1 (en) 1997-06-12
NO982582L (no) 1998-08-03
NO982582D0 (no) 1998-06-05
PL327144A1 (en) 1998-11-23
HUP0000110A3 (en) 2000-09-28
CZ174598A3 (cs) 1999-01-13
EA199800535A1 (ru) 1998-12-24
KR19990071977A (ko) 1999-09-27
JP2000501711A (ja) 2000-02-15
CA2239732A1 (en) 1997-06-12
AU715645B2 (en) 2000-02-10
NZ324594A (en) 1999-09-29
CN1208348A (zh) 1999-02-17
EP0866702A1 (de) 1998-09-30
HUP0000110A2 (hu) 2000-06-28
IL124786A0 (en) 1999-01-26
AU1147697A (en) 1997-06-27

Similar Documents

Publication Publication Date Title
IL126203A0 (en) Method for treating pain
EP0906104A4 (de) Schmerzbehandlungsverfahren
AU9035498A (en) Method for treating pain
IL122718A0 (en) Methods for treating diabetes
EP0874828A4 (de) Zusammensetzung für behandlungen von schmerzen
EP0827194A4 (de) Methode und apparat zur bearbeitung
IL126064A0 (en) Method for treating pain
IL125031A0 (en) Method for treating depression
GB9605828D0 (en) Treatment method
IL124786A0 (en) Method for treating pain
IL126063A0 (en) Method for treating migraine pain
GB9515868D0 (en) Therapeutic method
AU9034798A (en) Method for treating pain
EP0828507A4 (de) Verfahren zur behandlung von schmerz
IL124419A0 (en) Composition for treating pain
GB9516980D0 (en) Water treatment method
GB9501400D0 (en) Method for treating water
ZA971899B (en) Method for treating insomnia
GB9507825D0 (en) Method of treatment
GB9415902D0 (en) Method of treatment
GB9407335D0 (en) Method of treatment
GB9513130D0 (en) Treatment method
GB9513129D0 (en) Treatment method
GB9511594D0 (en) Treatment method
IL126160A0 (en) Method for treating insomnia

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980605

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/433 A, 7A 61P 29/00 B

A4 Supplementary search report drawn up and despatched

Effective date: 20010612

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020701